Format

Send to

Choose Destination
Biologicals. 2001 Sep-Dec;29(3-4):271-6.

The development of multi-epitope vaccines: epitope identification, vaccine design and clinical evaluation.

Author information

1
Epimmune Inc., 5820 Nancy Ridge Drive, San Diego, California 92121, U.S.A.

Abstract

We have developed efficient methods for epitope identification and vaccine design. Our process for epitope selection based on the combined use of motif analyses, binding assays and immunogenicity evaluations is described. We also describe how the projected population coverage and vaccine design can be optimized. Finally, it is discussed how vaccine potency is evaluated by immunogenicity and antigenicity assays.

PMID:
11851327
DOI:
10.1006/biol.2001.0297
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center